Daniel J. Drucker
✓ Source-basedrisingCanadian endocrinologist
Daniel Joshua Drucker is a Canadian endocrinologist renowned for his breakthrough discoveries of the biological actions of glucagon-like peptides GLP-1 and GLP-2, including GLP-1's key role in stimulating glucose-dependent insulin secretion, reducing food intake, protecting the heart, and reducing systemic...
Text from Wikipedia, CC BY-SA 4.0
Also inDeutsch
Awards 10
Connected to Daniel 6
Carl Ferdinand CoriAlso won Banting MedalPierre ChambonAlso won Fred Conrad Koch AwardRobert WeinbergAlso won Breakthrough Prize in Life Sciences
Maude AbbottAlso won Canadian Medical Hall of Fame
Pamela J. BjorkmanAlso won Wolf Prize in MedicineSvetlana MojsovAlso won Breakthrough Prize in Life SciencesAbout this person
Daniel Joshua Drucker is a Canadian endocrinologist renowned for his breakthrough discoveries of the biological actions of glucagon-like peptides GLP-1 and GLP-2, including GLP-1's key role in stimulating glucose-dependent insulin secretion, reducing food intake, protecting the heart, and reducing systemic inflammation. His scientific research has been a driving force in GLP-1's journey from a newly discovered peptide sequence to the mechanism behind globally used and life-changing therapeutics for type 2 diabetes and obesity. It has also driven transformative new therapeutics for intestinal failure and other metabolic disorders. A Fellow of the Royal Society, and laureate of the 2023 Wolf Prize in Medicine, he is a University Professor of Medicine at the University of Toronto and Senior Investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto.
Text from Wikipedia, CC BY-SA 4.0
CanadaFame.am measures public visibility signals. It does not measure human value, talent, morality, or credibility.